IOL Chemicals & Pharmaceuticals said that company's product, Ibuprofen has received an approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China.

Peethaambaran Kunnathoor, Chennai Tuesday, April 29, 2025, 08:00 Hrs [IST] ...

Photo shows Dr. Ron Cohen, founder, former chairman and CEO of Acorda Therapeutics, speaking at the healthcare symposium ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 7.27%, which has investors questioning if this is right time ...

If the goal of these cuts was to make the government leaner, the result has been to make it weaker. And in the realm of public health, weakness can be deadly.

A proposed 25% tariff on U.S. pharmacy imports would drive up U.S. drug costs by $51 billion annually, according to an analysis by Ernst & Young reviewed by Reuters. The April 22 analysis, ...

Americans sent a clear election message and delivered President Trump a clear mandate: Prices are way too high. While ...

TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...